Impact of GDMT in Uncontrolled Asthma Patients Receiving MHD Inhaled Corticosteroids + Long-acting β2 Agonist
Clinical trial NCT07718724 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07718724
- Sponsor
- AstraZeneca
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-15
- Primary completion
- 2028-04-30
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.